and others are evaluating new celiac disease drugs to improve the treatment landscape. Promising Celiac Disease pipeline therapies such as TAK-101, TAK-062, PRV-015, Latiglutenase, TAK-227, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback